All Stories

  1. Antithrombotic treatment in patients with atrial fibrillation and acute coronary syndromes: results of the European Heart Rhythm Association survey
  2. The influence of age on the psychological profile of patients with cardiac implantable electronic devices: results from the Italian population in a multicenter study conducted by the European Heart Rhythm Association
  3. Prevention of sudden cardiac death by the implantable cardioverter-defibrillator
  4. Risk stratification for complex ventricular arrhythmia complicating ST-segment elevation myocardial infarction
  5. Factors determining the choice between subcutaneous or transvenous implantable cardioverter-defibrillators in Poland in comparison with other European countries: a sub-study of the European Heart Rhythm Association prospective survey
  6. Outcomes in patients undergoing cardiac resynchronisation therapy complicated by device-related infective endocarditis
  7. European Heart Rhythm Association (EHRA) consensus document on management of arrhythmias and cardiac electronic devices in the critically ill and post-surgery patient, endorsed by Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), C...
  8. Translating guidelines into practice for the management of atrial fibrillation: results of an European Heart Rhythm Association Survey
  9. Management of patients with ventricular arrhythmias and prevention of sudden cardiac death—translating guidelines into practice: results of the European Heart Rhythm Association survey
  10. Left ventricular scar and the acute hemodynamic effects of multivein and multipolar pacing in cardiac resynchronization
  11. Peri-procedural routines, implantation techniques, and procedure-related complications in patients undergoing implantation of subcutaneous or transvenous automatic cardioverter-defibrillators: results of the European Snapshot Survey on S-ICD Implantati...
  12. Prognostic Significance of Complex Ventricular Arrhythmias Complicating ST-Segment Elevation Myocardial Infarction
  13. Cryoballoon ablation of atrial fibrillation in patients with advanced systolic heart failure and cardiac implantable electronic devices
  14. Factors influencing the use of subcutaneous or transvenous implantable cardioverter-defibrillators: results of the European Heart Rhythm Association prospective survey
  15. Ventricular fibrillation induced by a radiofrequency energy delivery for premature ventricular contractions arising from the right ventricular outflow tract – is ICD indicated?
  16. Use of leadless pacemakers in Europe: results of the European Heart Rhythm Association survey
  17. Clinical manifestations of device-related infective endocarditis in cardiac resynchronization therapy recipients
  18. Patients’ knowledge and attitudes regarding living with implantable electronic devices: results of a multicentre, multinational patient survey conducted by the European Heart Rhythm Association
  19. Management of ventricular tachycardia in the ablation era: results of the European Heart Rhythm Association Survey
  20. Long-term outcome of catheter ablation and other form of therapy for electrical storm in patients with implantable cardioverter-defibrillators
  21. Approach to cardio-oncologic patients with special focus on patients with cardiac implantable electronic devices planned for radiotherapy: results of the European Heart Rhythm Association survey
  22. Significance of Atrial Fibrillation Complicating ST-Segment Elevation Myocardial Infarction
  23. Catheter Ablation of Atrial Fibrillation: An Overview for Clinicians
  24. The Changing Landscape for Stroke Prevention in AF
  25. Cryoablation for treatment of cardiac arrhythmias: results of the European Heart Rhythm Association survey
  26. Device-related infective endocarditis in cardiac resynchronization therapy recipients — Single center registry with over 2500 person-years follow up
  27. Gender-related differences in long-term outcome among high-risk patients with myocardial infarction treated invasively
  28. The Incidence, Clinical Significance, and Treatment Effects of Depression in Cardiac Resynchronization Therapy Recipients
  29. Ultra-fast, high-density 3D mapping system for catheter ablation of infrequent, “unmappable” idiopathic ventricular arrhythmia – a case report.
  30. Automatyczny kardiowerter-defibrylator u chorych z nieischemiczną niewydolnością serca – czy wyniki badania Danish Trial są szokiem?
  31. Do we need to monitor the percentage of biventricular pacing day by day?
  32. Implantation of subcutaneous implantable cardioverter defibrillators in Europe: results of the European Heart Rhythm Association survey
  33. The Impact of Routine Angiographic Follow-Up in a Population of Patients Undergoing Percutaneous Coronary Intervention Within the Left Main Coronary Artery
  34. Prognostic value of collagen turnover biomarkers in cardiac resynchronization therapy: A subanalysis of the TRUST CRT randomized trial population
  35. In Heart Failure Patients with Left Bundle Branch Block Single Lead MultiSpot Left Ventricular Pacing Does Not Improve Acute Hemodynamic Response To Conventional Biventricular Pacing. A Multicenter Prospective, Interventional, Non-Randomized Study
  36. Polish and European management strategies in patients with atrial fibrillation. Data from the EURObservational Research Programme-Atrial Fibrillation General Registry Pilot Phase (EORP-AF Pilot)
  37. LV mechanical dispersion as a predictor of ventricular arrhythmia in patients with advanced systolic heart failure
  38. Day by day telemetric care of patients treated with cardiac resynchronisation therapy: first Polish experience
  39. The use of wearable cardioverter-defibrillators in Europe: results of the European Heart Rhythm Association survey
  40. Management of atrial fibrillation in patients with chronic kidney disease in Europe Results of the European Heart Rhythm Association Survey
  41. 2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death
  42. Liczba i wskaźniki objętości płytek krwi u chorych z wywołanym kontrastem ostrym uszkodzeniem nerek i zawałem serca leczonych inwazyjnie
  43. Stroke and death prediction with CHA2DS2-vasc score after myocardial infarction in patients without atrial fibrillation
  44. Atrial fibrillation in cardiac resynchronization recipients with and without prior arrhythmic history. How much of arrhythmia is too much?
  45. Can we rely on machines? Device-detected atrial high rates correspond well with atrial arrhythmias in cardiac resynchronization recipients
  46. Quality of Life in Cardiac Resynchronization Recipients: Association with Response and Impact on Outcome
  47. Naprzemienny blok prawej i lewej odnogi pęczka Hisa
  48. Skuteczność terapii resynchronizującej w leczeniu pacjentów ze schyłkową niewydolnością serca zależnych od leków inotropowych
  49. 2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy
  50. Trying to predict the unpredictable: Variations in device-based daily monitored diagnostic parameters can predict malignant arrhythmic events in patients undergoing cardiac resynchronization therapy
  51. Sleep-disordered breathing and echocardiographic measures of function and dyssynchrony
  52. Long-term outcomes of cardiac resynchronization therapy are worse in patients who require atrioventricular junction ablation for atrial fibrillation than in those with sinus rhythm
  53. Contrast-induced acute kidney injury in patients undergoing cardiac resynchronization therapy—incidence and prognostic importance. Sub-analysis of data from randomized TRUST CRT trial
  54. Prognostic significance of HbA1c in patients with AMI treated invasively and newly detected glucose abnormalities
  55. Catheter ablation of atrial fibrillation: current status, techniques, outcomes and challenges
  56. The incidence and risk factors of stroke in patients with acute myocardial infarction treated invasively and concomitant impaired renal function
  57. Migotanie przedsionków u chorej z utajonym zespołem Wolffa-Parkinsona-White’a
  58. Is it important to monitor the percentage of cardiac resynchronization day by day?
  59. The risk of contrast-induced nephropathy and its prognostic significance in patients with different glucose abnormalities and acute myocardial infarction treated invasively
  60. Trying to predict the unpredictable:device-based daily monitored parameters can predict malignant arrhythmic events in patients undergoing cardiac resynchronization
  61. Lack of improvement in quality of life after cardiac resynchronization therapy is a potent determinant of unfavorable outcomes independently from functional and echocardiographic response
  62. Atrial fibrillation types predict the development of contrast-induced nephropathy in patients with acute myocardial infarction treated invasively
  63. The incidence, clinical significance of depression and changes in its clinical course after a cardiac device implantation in patients with congestive heart failure
  64. Upgrade of implantable cardioverter-defibrillator to Cardiac Resynchronization Therapy with Defibrillator (CRT-D). In which patients shall we expect?
  65. Wielopunktowa stymulacja dwukomorowa w terapii resynchronizującej serce
  66. Many response criteria are poor predictors of outcomes after cardiac resynchronization therapy: validation using data from the randomized trial
  67. Burza elektryczna w erze pacjentów z kardiowerterem-defibrylatorem
  68. Pacemaker endocarditis – did we let the genie out of the bottle? Comment on "Implantation of an epicardial lead through mini-thoracotomy as an alternative for patients with lead-related endocarditis who require permanent pacing"
  69. Effect of Type of Atrial Fibrillation on Prognosis in Acute Myocardial Infarction Treated Invasively
  70. Implantation Feasibility, Procedure-Related Adverse Events and Lead Performance During 1-Year Follow-Up in Patients Undergoing Triple-Site Cardiac Resynchronization Therapy: A Substudy of TRUST CRT Randomized Trial
  71. The risk of stroke in patients with acute myocardial infarction treated invasively
  72. The prognostic value of different glucose abnormalities in patients with acute myocardial infarction treated invasively
  73. Effect of Cardiac Resynchronization on Gradient Reduction in Patients with Obstructive Hypertrophic Cardiomyopathy: Preliminary Study
  74. The impact of unsuccessful percutaneous coronary intervention on short- and long-term prognosis in STEMI and NSTEMI
  75. The Incremental Value of Right Ventricular Indices for Predicting Response to Cardiac Resynchronization Therapy
  76. Assessment of apical rocking: a new, integrative approach for selection of candidates for cardiac resynchronization therapy
  77. Early therapy following myocardial infarction: arguments for and against implantable cardioverter-defibrillators
  78. Effect of Anemia in High-Risk Groups of Patients With Acute Myocardial Infarction Treated With Percutaneous Coronary Intervention
  79. Transseptal versus transaortic approach for radiofrequency ablation in patients with cardioverter–defibrillator and electrical storm
  80. Prognostic Significance of Hyperuricemia in Patients with Different Types of Renal Dysfunction and Acute Myocardial Infarction Treated with Percutaneous Coronary Intervention
  81. Triple-Site Versus Standard Cardiac Resynchronization Therapy Study (TRUST CRT): Clinical Rationale, Design, and Implementation
  82. Effects of Cardiac Resynchronization Therapy on Heart Rate Turbulence
  83. Mid-term outcomes of triple-site vs. conventional cardiac resynchronization therapy: A preliminary study
  84. Premature Complexes, Atrial and Ventricular
  85. Sleep apnoea as a predictor of mid- and long-term outcome in patients undergoing cardiac resynchronization therapy
  86. Evaluation of left ventricular systolic and diastolic function in patients with atrioventricular re-entrant tachycardia treated by radiofrequency current ablation
  87. Doppler predictors of inducibility of atrial fibrillation in patients with WPW syndrome and atrioventricular re-entrant tachycardia
  88. Sequence of electrical activation, atrial remodelling and atrial fibrillation in patients with nodal re-entrant tachycardia
  89. Triple-site biventricular pacing in patients undergoing cardiac resynchronization therapy: a feasibility study
  90. Resynchronization or Dyssynchronization?Successful Treatment with Biventricular Stimulation of a Child with Obstructive Hypertrophic Cardiomyopathy without Dyssynchrony
  91. Triple site biventricular pacing in a patient with congestive heart failure and severe mechanical dyssynchrony
  92. Different Types of Renal Dysfunction in Patients with Acute Myocardial Infarction Treated with Percutaneous Coronary Intervention
  93. Importance of complete revascularization in patients with acute myocardial infarction treated with percutaneous coronary intervention
  94. Influence of Reciprocating Tachycardia on the Development of Atrial Fibrillation in Patients with Preexcitation Syndrome
  95. 172 Sleep apnea in patients with cardiac resynchronization therapy - what role plays an echocardiography: background, equal or just a helping hand?
  96. 394 The influence of cardiac resynchronization therapy on right ventricular systolic function in heart failure patients with right ventricular impairment
  97. Effect of Percutaneous Interventions within the Coronary Sinus on the Success Rate of the Implantations of Resynchronization Pacemakers
  98. Coronary sinus stenting for the stabilization of left ventricular lead during resynchronization therapy
  99. A37-4 Surface ECG can predict peri-hisian localization of ectopic focus in patients undergoing radiofrequency ablation of idiopatic right ventricular arrhythmia
  100. P-266 Sequence of atrio-ventricular electrical excitation during nodal reentry tachycardia influences the development of atriomyopathy
  101. P-089 Radiofrequency catheter ablation in patients with congenital heart disease
  102. P-164 Trend of heart rate variability in patients treated with cardiac resynchronization therapy
  103. P-043 The evaluation of paroxysmal atrial fibrillation using event holter loop recording
  104. A05-2 Atrial pressures during reciprocating tachycardia as a risk factor for atrial fibrillation in WPW-patients
  105. A24-2 Atrial conduction velocity is a marker of atriomyopathy progression in patients with atrial flutter
  106. A37-4 Surface ecg can predict peri-hisian localization of ectopic focus in patients undergoing radiofrequency ablation of idiopatic right ventricular arrhythmia
  107. P-266 Sequence of atrio-ventricular electrical excitation during nodal reentry tachycardia influences the development of atriomyopathy
  108. Electrophysiological Features of Orthodromic Atrioventricular Reentry Tachycardia in Patients with Wolff-Parkinson-White Syndrome and Atrial Fibrillation
  109. P354 Sequence of atrio-ventricular electrical excitation during nodal reentry tachycardia influences the development of atriomyopathy